February 27, 2024

Spotlight on CDER Science

Safety Outcomes When “Switching” Between Biosimilars and Reference Products Biological products (biologics) play an important role in clinical care, providing safe and effective treatments for many […]
February 27, 2024

EzriCare LLC – 658390 – 02/13/2024

Delivery Method: VIA EMAIL WITH READ RECEIPT Product: Drugs Recipient: Recipient Name Mr. Ezriel Green Recipient Title Owner/Chief Executive Officer EzriCare LLC 1525 Prospect Street, Suite […]
February 27, 2024

Delsam Pharma LLC – 657340 – 02/13/2024

Delivery Method: Via Electronic Mail – Delivery and Read Receipt Requested Product: Drugs Recipient: Recipient Name Mr. Kuppusamy Arumugam Recipient Title President / Owner Delsam Pharma […]
February 27, 2024

LightEyez Limited – 665450 – 02/15/2024

Delivery Method: VIA UPS Product: Drugs Recipient: Recipient Name Dr. Charlie Carmichael Recipient Title Chief Executive Officer LightEyez Limited The News Building3 London Bridge StreetLondonSE1 9SGUnited […]
February 27, 2024

Patient Medication Information (PMI)

Background FDA is proposing to amend its human prescription drug labeling regulations to require a new type of Medication Guide—”Patient Medication Information” (PMI)—for prescription drug products […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0